IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

Clinical trial NCT07198841 · RECRUITING

Trial details

NCT number: NCT07198841
Sponsor: Guangdong Association of Clinical Trials
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer (Non-Small Cell)

Start date: 2025-11-03
Primary completion: 2027-09-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.